DAB2IP — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Apomorphine (SCHEMBL8524)	1.00	1/20
SCHEMBL225052	1.00	1/20
SCHEMBL225053	1.00	1/20
Apomorphine (SCHEMBL5904190)	1.00	1/20
SCHEMBL6010005	1.00	1/20
Apomorphine (SCHEMBL232473)	0.98	1/20
Apomorphine (SCHEMBL1321033)	0.98	1/20
Apomorphine (SCHEMBL4755216)	0.98	1/20
Apomorphine (SCHEMBL5429071)	0.98	1/20
Apomorphine (SCHEMBL2256775)	0.89	1/20
SCHEMBL2617357	0.84	1/20
SCHEMBL3868013	0.84	1/20
SCHEMBL4206793	0.84	1/20
SCHEMBL4206797	0.84	1/20
SCHEMBL5025553	0.84	1/20
SCHEMBL960282	0.82	1/20
SCHEMBL3972093	0.82	1/20
SCHEMBL3972095	0.82	1/20
SCHEMBL4061425	0.82	1/20
SCHEMBL4749406	0.82	1/20

Clinical trials — most relevant to DAB2IP by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients	PHASE2	COMPLETED
Genetic Characterization of Parkinson's Disease	nan	COMPLETED
Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin	nan	RECRUITING
Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration	nan	UNKNOWN
Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study	nan	COMPLETED
Research and Characterization of New Genes Involved in Intellectual Disability	nan	COMPLETED
Evaluation of CEMIP in Pancreatic Cancer	nan	UNKNOWN
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)	nan	RECRUITING
Immune Cell Response to Stimuli	nan	RECRUITING
Search for Phenotype-modifying Genes in Patients With Intellectual Disabilities.	nan	NOT_YET_RECRUITING
Study of the Genetic Factors Involved in Autism and Related Disorders	nan	RECRUITING
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA	nan	RECRUITING
Muscle Tissue Bank for Muscular Dystrophy	nan	COMPLETED
Gait in Rare Diseases	nan	COMPLETED
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)	nan	COMPLETED
Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs	nan	UNKNOWN
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing	nan	UNKNOWN
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.	nan	UNKNOWN
Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy.	nan	COMPLETED
Action Medical Research	nan	COMPLETED
Evaluation of Brain Dysfunction in Patients with Duchene Muscular Dystrophy	nan	NOT_YET_RECRUITING
Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder	nan	RECRUITING
Genetic Analysis of Hereditary Disorders of Hearing and Balance	nan	COMPLETED
Biomarker Research in Inherited Movement Disorders	nan	RECRUITING
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease	nan	UNKNOWN
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study	nan	COMPLETED
CNKSR2 Natural History Study	nan	RECRUITING
Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study	nan	UNKNOWN
Exome Analysis in Hearing Impaired Patients	nan	UNKNOWN
Genetics and Psychopathology in the 22q11 Deletion Syndrome	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a DAB2IP binder may also engage these)

Protein	Name	Similarity
Q3UHC7	—	1.000	Q3UHC7 →
F6SEU4	—	1.000	F6SEU4 →
Q6P730	—	1.000	Q6P730 →
Q9QUH6	—	0.997	Q9QUH6 →
Q96PV0	—	0.997	Q96PV0 →
Q9UJF2	—	0.995	Q9UJF2 →
Q5PRF9	—	0.994	Q5PRF9 →
Q9H329	—	0.993	Q9H329 →
Q9BQI7	—	0.993	Q9BQI7 →
Q8R0S2	—	0.993	Q8R0S2 →
Q6DN90	—	0.992	Q6DN90 →
MAP3K9	Mitogen-activated protein kinase kinase kinase 9	0.992	landscape →
O15013	—	0.992	O15013 →
Q80XS6	—	0.992	Q80XS6 →
Q8TDY4	—	0.992	Q8TDY4 →
Q9ES67	—	0.992	Q9ES67 →
O60292	—	0.991	O60292 →
Q6P1I6	—	0.991	Q6P1I6 →
Q2TAL5	—	0.991	Q2TAL5 →
Q1LYM3	—	0.991	Q1LYM3 →
Q8MLZ5	—	0.991	Q8MLZ5 →
O43182	—	0.991	O43182 →
Q9VLW2	—	0.991	Q9VLW2 →
Q6ZSZ5	—	0.990	Q6ZSZ5 →
O14827	—	0.990	O14827 →
A9C3W3	—	0.990	A9C3W3 →
E1BFE9	—	0.990	E1BFE9 →
Q6UXY1	—	0.990	Q6UXY1 →
Q8JZP9	—	0.990	Q8JZP9 →
A1Z7A6	—	0.989	A1Z7A6 →